Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
As of today (2026-08-02), the Forward Annual Dividend Yield of Sedana Medical AB is 0.00%.
As of today (2026-08-02), the Trailing Annual Dividend Yield of Sedana Medical AB is 0.00%.
FRA:7D2A's Forward Dividend Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.105 * Ranked among companies with meaningful Forward Dividend Yield % only.
Sedana Medical AB (FRA:7D2A) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Sedana Medical AB Forward Dividend Yield % Related Terms
FRA:7D2A vs ABT, SYK, MDT: Forward Dividend Yield % Comparison
For the Medical Devices subindustry, Sedana Medical AB's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sedana Medical AB Forward Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Sedana Medical AB's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Sedana Medical AB's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Sedana Medical AB (FRA:7D2A) has a Forward Dividend Yield % of 0.00% as of Aug. 02, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Sedana Medical AB and its competitors. According to the industry distribution chart, Sedana Medical AB ranks #999999 out of 312 companies in the Medical Devices & Instruments industry.
Is Sedana Medical AB's Forward Dividend Yield % too high?
Sedana Medical AB's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Sedana Medical AB ranks #999999 out of 312 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Sedana Medical AB has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Sedana Medical AB's Forward Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Sedana Medical AB ranks #999999 out of 312 companies for Forward Dividend Yield %. This places Sedana Medical AB in the lower half of its industry. The industry median Forward Dividend Yield % is 2.11. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.11, based on 312 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Sedana Medical AB and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sedana Medical AB's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sedana Medical AB stock overvalued right now?
Sedana Medical AB (FRA:7D2A) has a current Forward Dividend Yield % of 0.00%. The stock's GF Value™ is €1.47, compared to a current price of €0.86 — trading 41.7% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Sedana Medical AB's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Sedana Medical AB (FRA:7D2A), the current Forward Dividend Yield % is 0.00% as of Aug. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Sedana Medical AB (FRA:7D2A) Overvalued in 2026?
Based on GuruFocus' analysis, Sedana Medical AB stock appears to be undervalued.
The current stock price of €0.86 is trading 41.7% below its estimated GF Value™ of €1.47.
Key valuation signals for FRA:7D2A:
Forward Dividend Yield %: 0.00%
GF Value™: €1.47 vs. price of €0.86 (41.7% below fair value)
No single metric tells the full story. See the FRA:7D2A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Sedana Medical AB is a Sweden-based medical technology company. It is ais a pioneer medtech and pharmaceutical company focused on inhaled sedation to improve the patient's life during and beyond sedation. Through the combined strengths of the medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane), Sedana Medical provides inhaled sedation for mechanically ventilated patients in intensive care. Sedana Medical has direct sales in Benelux, France, Germany, Great Britain, and Spain. In other parts of Europe, as well as in Asia, Australia, Canada, and South and Central America, the company works with external distributors.
69GF Score
Get the complete analysis for FRA:7D2A
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:7D2A has been successfully added to your 
